Requirement of decreased O-GlcNAc glycosylation of Mef2D for its recruitment to the myogenin promoter

Biochemical and Biophysical Research Communications

Volumn 433, Issue 4, 2013, Pages 558-562

  Ogawa, Mitsutaka ^a   Sakakibara, Yuki ^a   Kamemura, Kazuo ^a  

^a NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Glycosylation; Mef2D; Myogenesis; Myogenin; O GlcNAc

Indexed keywords

MEF2D PROTEIN; MYOGENIN; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE DELETION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ACETYLGLUCOSAMINE; ANIMALS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOSYLATION; HEK293 CELLS; HUMANS; MADS DOMAIN PROTEINS; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUTAGENESIS, SITE-DIRECTED; MYOBLASTS; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; MYOGENIN; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; TRANSFECTION;

EID: 84876492178     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.033     Document Type: Article

References (21)

1. Hart G.W., Slawson C., Ramirez-Correa G., Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 2011, 80:825-858.
2. Hanover J.A., Krause M.W., Love D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 2012, 13:312-321.
3. Li X., Molina H., Huang H., Zhang Y.Y., Liu M., Qian S.W., Slawson C., Dias W.B., Pandey A., Hart G.W., Lane M.D., Tang Q.Q. O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. J. Biol. Chem. 2009, 284:19248-19254.
4. Ishihara K., Takahashi I., Tsuchiya Y., Hasegawa M., Kamemura K. Characteristic increase in nucleocytoplasmic protein glycosylation by O-GlcNAc in 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 2010, 398:489-494.
5. Kim S.H., Kim Y.H., Song M., An S.H., Byun H.Y., Heo K., Lim S., Oh Y.S., Ryu S.H., Suh P.G. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2. Biochem. Biophys. Res. Commun. 2007, 362:325-329.
6. Andrés-Bergós J., Tardio L., Larranaga-Vera A., Gómez R., Herrero-Beaumont G., Largo R. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J. Biol. Chem. 2012, 287:33615-33628.
7. Yanagisawa M., Yu R.K. O-linked beta-N-acetylglucosaminylation in mouse embryonic neural precursor cells. J. Neurosci. Res. 2009, 87:3535-3545.
8. Liu Y., Li X., Yu Y., Shi J., Liang Z., Run X., Li Y., Dai C.L., Grundke-Iqbal I., Iqbal K., Liu F., Gong C.X. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain. PLoS One 2012, 7:e43724.
9. Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G., Kitagawa H., Kato S. GlcNAcylation of a histone methyltransferase in retinoic acid-induced granulopoiesis. Nature 2009, 459:455-459.
10. Ogawa M., Mizofuchi H., Kobayashi Y., Tsuzuki G., Yamamoto M., Wada S., Kamemura K. Terminal differentiation program of skeletal myogenesis is negatively regulated by O-GlcNAc glycosylation. Biochim. Biophys. Acta 2012, 1820:24-32.
11. Potthoff M.J., Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 2007, 134:4131-4140.
12. Matsuyama A., Shimazu T., Sumida Y., Saito A., Yoshimatsu Y., Seigneurin-Berny D., Osada H., Komatsu Y., Nishino N., Khochbin S., Horinouchi S., Yoshida M. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002, 21:6820-6831.
13. Yuzwa S.A., Macauley M.S., Heinonen J.E., Shan X., Dennis R.J., He Y., Whitworth G.E., Stubbs K.A., McEachern E.J., Davies G.J., Vocadlo D.J. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 2008, 4:483-490.
14. Comer F.I., Vosseller K., Wells L., Accavitti M.A., Hart G.W. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 2001, 293:169-177.
15. Khidekel N., Arndt S., Lamarre-Vincent N., Lippert A., Poulin-Kerstien K.G., Ramakrishnan B., Qasba P.K., Hsieh-Wilson L.C. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. J. Am. Chem. Soc. 2003, 125:16162-16163.
16. Martin J.F., Miano J.M., Hustad C.M., Copeland N.G., Jenkins N.A., Olson E.N. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 1994, 14:1647-1656.
17. Russo S., Tomatis D., Collo G., Tarone G., Tatò F. Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. J. Cell Sci. 1998, 111:691-700.
18. Ohkawa Y., Marfella C.G., Imbalzano A.N. Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1. EMBO J. 2006, 25:490-501.
19. Ohkawa Y., Yoshimura S., Higashi C., Marfella C.G., Dacwag C.S., Tachibana T., Imbalzano A.N. Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis. J. Biol. Chem. 2007, 282:6564-6570.
20. Molkentin J.D., Li L., Olson E.N. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA-binding activity. J. Biol. Chem. 1996, 271:17199-17204.
21. Wang X., Tang X., Li M., Marshall J., Mao Z. Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival. J. Biol. Chem. 2005, 280:16705-16713.